FDA Accepts Interim Analysis Plan for Ongoing Phase 2b Ibezapolstat Clinical Trial and Acurx Announces Presentations at ECCMID 2023 Scientific Conference Apr 11, 2023
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update Mar 16, 2023
Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update Mar 6, 2023
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2022 Results and Provides Business Update Nov 14, 2022
Acurx Pharmaceuticals, Inc. to Discuss 2022 Third Quarter Financial Results on November 14, 2022 Conference Call and Provide Business Update Nov 1, 2022
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2022 Results and Provides Business Update Aug 15, 2022
Acurx Pharmaceuticals, Inc. to Discuss 2022 Second Quarter Financial Results on August 16, 2022 Conference Call and Provide Business Update Aug 4, 2022
